Dianthus Therapeutics Inc. (DNTH) financials · rev $2.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Dianthus Therapeutics Inc. (DNTH) rev $2.0M.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $2.04M | $6.24M | |
| Operating Income | −$177.93M | −$101.86M | |
| Net Income | −$162.34M | −$84.97M | |
| EPS (Diluted) | −$4.20 | −$2.55 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $530.92M | $374.01M | |
| Current Assets | $409.44M | $280.90M | |
| Cash & Equivalents | $51.09M | $22.79M | |
| PP&E | $296.00K | $194.00K | |
| Total Liabilities | $37.52M | $21.53M | |
| Current Liabilities | $30.73M | $18.45M | |
| Shareholders' Equity | $493.40M | $352.48M | |
| Retained Earnings | −$336.73M | −$174.39M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$129.06M | −$78.18M | |
| CapEx | $213.00K | $105.00K | |
| Investing Cash Flow | −$122.83M | −$286.81M | |
| Financing Cash Flow | $280.13M | $255.62M | |
| Net Change in Cash | $28.23M | −$109.37M | |
| Free Cash Flow | −$129.27M | −$78.28M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is DNTH P/E and revenue?
Dianthus Therapeutics Inc. (DNTH) rev $2.0M.
What is DNTH revenue?
Dianthus Therapeutics Inc. last cached revenue is $2.04M (FY2025).
Is DNTH profitable?
Dianthus Therapeutics Inc. last cached net income is -$162.3M (FY2025).
What are DNTH total assets?
Dianthus Therapeutics Inc. last cached total assets are $530.9M (FY2025).
What is DNTH free cash flow?
Dianthus Therapeutics Inc. last cached free cash flow is -$129.3M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.